Search by Drug Name or NDC
NDC 63824-0744-16 Cepacol 7.5; 5 mg/1; mg/1 Details
Cepacol 7.5; 5 mg/1; mg/1
Cepacol is a ORAL LOZENGE in the HUMAN OTC DRUG category. It is labeled and distributed by RB Health (US) LLC. The primary component is BENZOCAINE; DEXTROMETHORPHAN HYDROBROMIDE.
Product Information
| NDC | 63824-0744 |
|---|---|
| Product ID | 63824-744_0650e5e8-1241-6c92-e063-6394a90ac9c0 |
| Associated GPIs | 88209902204725 |
| GCN Sequence Number | 063802 |
| GCN Sequence Number Description | dextromethorphan/benzocaine LOZENGE 5MG-7.5MG ORAL |
| HIC3 | H6C |
| HIC3 Description | ANTITUSSIVES, NON-OPIOID |
| GCN | 99512 |
| HICL Sequence Number | 001911 |
| HICL Sequence Number Description | DEXTROMETHORPHAN HBR/BENZOCAINE |
| Brand/Generic | Brand |
| Proprietary Name | Cepacol |
| Proprietary Name Suffix | Extra Strength Sore Throat and Cough |
| Non-Proprietary Name | BENZOCAINE and DEXTROMETHORPHAN HYDROBROMIDE |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | LOZENGE |
| Route | ORAL |
| Active Ingredient Strength | 7.5; 5 |
| Active Ingredient Units | mg/1; mg/1 |
| Substance Name | BENZOCAINE; DEXTROMETHORPHAN HYDROBROMIDE |
| Labeler Name | RB Health (US) LLC |
| Pharmaceutical Class | Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Standardized Chemical Allergen [EPC], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA R |
| DEA Schedule | n/a |
| Marketing Category | OTC MONOGRAPH NOT FINAL |
| Application Number | part356 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 63824-0744-16 (63824074416)
| NDC Package Code | 63824-744-16 |
|---|---|
| Billing NDC | 63824074416 |
| Package | 2 BLISTER PACK in 1 CARTON (63824-744-16) / 8 LOZENGE in 1 BLISTER PACK |
| Marketing Start Date | 2014-05-05 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 0.15081 |
| Pricing Unit | EA |
| Effective Date | 2023-12-20 |
| NDC Description | CEPACOL SORE THROAT-COUGH LOZ |
| Pharmacy Type Indicator | C/I |
| OTC | Y |
| Explanation Code | 2, 6 |
| Classification for Rate Setting | B |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis